Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ossium Health, Inc.
Thomas Jefferson University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Columbia University
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
M.D. Anderson Cancer Center